Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P14
Within normal range
vs 3Y Ago
-1.3x
Contraction
Streak
3 yr
Consecutive declineDecelerating
PeriodValue
2025-71.97%
2024-57.14%
202336.84%
202254.61%
202117.70%
2020-41.83%
201989.02%
2018-0.40%
201710.53%
201623.65%